Patent: 6,927,044
✉ Email this page to a colleague
Summary for Patent: 6,927,044
Title: | IL-1 receptor based cytokine traps |
Abstract: | Fusion polypeptides capable of binding interleukin-1 (IL-1) to form a nonfunctional complex are provided and nucleic acid molecules encoding the fusion polypeptides. The fusion ploypeptides form dimers to function as IL-1 antagonists. |
Inventor(s): | Stahl; Neil (Carmel, NY), Yancopoulos; George D. (Yorktown Heights, NY) |
Assignee: | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) |
Application Number: | 10/282,162 |
Patent Claims: | see list of patent claims |
Details for Patent 6,927,044
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST | rilonacept | For Injection | 125249 | 02/27/2008 | ⤷ Try a Trial | 2018-09-25 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,927,044
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 283365 | ⤷ Try a Trial |
Austria | 336583 | ⤷ Try a Trial |
Austria | 420970 | ⤷ Try a Trial |
Australia | 2003284895 | ⤷ Try a Trial |
Australia | 6499499 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |